
    
      A prospective randomized controlled study was designed to be carried out by enrolling 40
      patients underwent surgery for joint replacement from October 2020 to February 2021. The
      experimental group: Oral administration of Pregabalin (37.5mg) at 8 am and 18 pm 1 d before
      operation; oral administration of Pregabalin (75mg) 2h before operation; and oral
      administration of Pregabalin (75mg) at 18 pm from the first day after operation to discharge
      (n=20). The control group: Oral administration of Pregabalin (75mg) 2h before operation; and
      oral administration of Pregabalin (75mg) at 18 pm from the first day after operation to
      discharge (n=20).
    
  